News Release
Cool Japan Fund Inc.
Tokyo, May 8, 2018

LP Investment in a Fund that Aims to Nurture Globally Competitive
Venture Businesses Mainly in Healthcare and Advanced Technology Industries

Cool Japan Fund is pleased to announce the decision to invest a maximum of 1 billion yen
in MIYAKO Kyoto University Innovation L.P. (“the Fund”), which is operated by MIYAKOCapital Co., Ltd. (“Miyako Capital”). Miyako Capital invests in and provides support forventure businesses with prominent outcome in research and development primarily inhealthcare and advanced technology industries, in partnership with several domestic andinternational universities and research institutes including Kyoto University.
Through the Fund, Cool Japan Fund aims to provide risk money to venture companies inthese fields, which tend to run short of capital, in order to nurture globally competitivebusinesses.

Miyako Capital is a venture capital that invests in and provides support to venture businesses
with prominent outcome in research and development in the field of regenerative medicine,
medical equipment, AI/IoT, and chemistry and materials in healthcare and advanced technology
industries, in partnership with several domestic and international universities and research
institutes including Kyoto University. In November 2015, Miyako Capital established the Fundand raised capital from megabanks, regional financial institutions and a number of institutional
and individual investors. To date, it has invested in 17 venture companies in Japan and overseas
through the fund.
For the success of a venture company with promising research findings, it is necessary tocapture vigorous global demand by commercializing the state-of-the-art products and services.
In healthcare and advanced technology industries, however, venture businesses tend to run shortof capital despite Japan’s internationally praised research achievements. Therefore, they facechallenges in commercializing the products and services and in expanding their businesses into
global markets.
Especially for overseas business expansion, the significance of financing facilitation ishighlighted by the guideline for Asia Health and Human Well-Being Initiative (implementedby the Headquarters for Healthcare and Medical Strategy Promotion July 2016)1 . Along with
the initiative, Cool Japan Fund has also worked with the healthcare industry as one of its
investment targets.
Cool Japan Fund has decided to invest a maximum of 1 billion yen in the Fund through its
additional fundraising process to provide venture companies with promising research results inhealthcare and advanced technology industries with risk money in order for these companies togrow into global players. The Fund has in-total raised about 7.3 billion yen from Cool Japan
Fund and other investors.
Contact for details regarding this document:
Cool Japan Fund (PR representatives: Yuge, Okuyama) Tel: +81-03-6406-7500

Leveraging Miyako Capital's global networks, Cool Japan Fund will, through the Fund,nurture globally competitive Japanese venture companies in these industries and contribute to
the development of the industries by increasing the presence of Japanese brands.
MIYAKO Kyoto University Innovation L.P.
Established:
November 2015
General Partner:
MIYAKO Capital Co., Ltd.
Fund Size:
About 7.3 billion yen
Fund Term:
Until the end of December 2024 (10 years)
MIYAKO Capital Co., Ltd.
Established:
September 2013
Location:
Sakyo-ku, Kyoto (Kyoto University)
Representative Directors: Satoshi Yamaguchi, Tsunesaburo Sugaya, Hiroaki Okahashi
Business Description:
Venture capital business
Website:http://www.miyakocapital.com/1“To facilitate financing for overseas businesses that will contribute to the promotion of Asia Health and Human Well-Being Initiative,
including healthcare providers, through the active utilization of financial support, such as overseas investment and lending by JICA, feasibility
study support, investment by Cool Japan Fund, and lending by Japan Bank for International Cooperation (JBIC) to produce specific cases,
learn required tasks, and address the problems.” (Excerpt from the guideline for Asia Health and Human Well-Being Initiative, July 2016)

Contact for details regarding this document:Cool Japan Fund (PR representatives: Yuge, Okuyama) Tel: +81-03-6406-7500